The relationship and clinical significance of TMS1,MBD2 and DNMT1 in hepatocellular carcinoma / 国际检验医学杂志

ABSTRACT

Objective To observe the expression of methylation related silent target 1 (TMS1),DNA methyltransferase 1 (DNM T1)and methyl CpG binding domain protein 2 (MBD2),and the methylation of the TMS1 gene promoter,in hepatocellular carcinoma (HCC),and to investigate the relationship between the three genes and the clinical diagnostic significance.Methods The protein expression of TMS1,MBD2 and DNMT1 in 48 cases of HCC tissues and 48 case of normal tissues were detected by immunohistochemistry (IHC);the methylation status of TMS1 gene in serum of 34 patients with HCC,26 patients with hepatitis B and 23 healthy controls were analyzed by methylation specific polymerase chain reaction (MSP).Results The posi-tive rates of TMS1 expression in HCC tissues and normal tissues were 26.08% and 97.92%,respectively;the positive rate of MBD2 expression were 18.75% and 80.00%,respectively;the positive rate of expression were 77.08 % and 32.25%,respectively.The positive rates of TMS1 and MBD2 expression in HCC tissues were significantly lower than those in the normal tissues,and DNM T1 expression was higer than that in the normal tissues,and the difference was statistically significant (P<0.05).The expression TMS1 and MBD2 were neg-atively correlated with DNMT1 (P< 0.05).TMS1 protein expression was associated with TNM stage and tumor differentiation but not associated with the age and gender (P<0.05).The methylation detection rates of TMS1 gene in HCC group,hepatitis B group and healthy group were 70.6%,50.0% and 0.0%,respective-ly,and the differences were statistically significant (P<0.05).The methylation detection rate of HCC group and hepatitis b group was obviously higher than the normal group,which aggravated with the increase of tumor grade and stage.Conclusion TMS1 hypermethylation may be an early event in the carcinogenesis of liver tissue,the abnormal expression of TMS1,MBD2 and DNM T1 proteins plays an important role in the oc-currence and the development of HCC,w hich can be used as new molecular markers for the early diagnosis and prognosis of HCC,and become the new targets for the treatment of HCC.